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Carcinoidtumorsoftheextrahepatic bileductare
rare and account for only 0.2-2% of all
gastrointestinal carcinoids 1,
CASE REPORT
A 30 yr old man presented with obstructive
jaundice while on holiday in Australia. Physical
examination was otherwise normal. Abdominal
ultrasound, CT scan and MRI scan confirmed
marked dilatation of the intrahepatic biliary
system. ERCPrevealedastrictureinthecommon
hepatic duct (Figure 1). A stent was inserted.
Brush cytology was inconclusive. CA19-9 and
CEA levels were normal. Following return to the
UK, laparotomy was performed and revealed a
3cm tumour at the junction of cystic duct and
CHD. Excision of the bile duct with portal
lymphadenectomy and Roux-en-Y
hepaticojejunostomy was performed. He had an
uneventful postoperative course.
Histopathology revealed a white firm tumour
obliteratingthelumenoftheCHD.Microscopically,
the tumour contained round and polygonal cells
arranged in nests and separated by fibrous stroma.
Tumour cells were tested for neuroendocrine
markers incuding chromogranin S and serotonin,
butwerepositiveonlyforprotein genepeptide and
neuronespecificenolase(Figure2). Ultrastructural
appearancesonelectronmicroscopyshoweddense-
cored neuroendocrine granules consistent with a
mid-gut carcinoid tumour. Margins were free of
tumourbut one outofeleven lymphnodes showed
a metastatic deposit.
Postoperatively, gastrointestinal hormone levels
includingNeurokininA,GastrinReleasePeptide,
and Pancreatic Polypeptide were normal. Daily
urinary excretion of 5 hydroxyindoleacetic acid
(5-HIAA) was also within the normal range.
SPECT octreotide scan did not reveal any
metastases and he remains well at follow up 18
months later.
DISCUSSION
Carcinoid tumours of the bile duct are rare. As
with other tumors of the bile duct, these lesions
aredifficulttodiagnosepreoperativelyandnearly
impossible to distinguish from
cholangiocarcinoma. They are derived from
embryonal neural crest cells (Kulchitsky cells)
and have the potential to produce serotonin3.
These cells are also known as argentaffin cells,
because of their affinity for silver staining
compounds and are located in the crypts of
Leiberkuhn.
Most ofthe information aboutthis malignancy is
from case reports. A comprehensive search of
Medline and Embase revealed forty two cases of
carcinoid ofthe extrahepatic duct, including our
case. In 1959, Davies first published a case of
biliary carcinoid although this may have been a
periampullary carcinoid4. Pilz has been credited
with the first reported case of carcinoid of the
biliary tract5. Clinical characteristics, pathology
and follow up data ofpreviously described cases
are summarized in Table 1[3-22].
The age of patients ranged from 12 to 79 years
withamedianof47years12' 13. Thefemaleto male
ratio was 2:1. The commonest symptom was
jaundice (69% of cases), often associated with
abdominal pain (30%) and pruritis (21%).
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Fig 1. ERCP showing a stricture in the common hepatic
duct (arrow)
Investigations ranged from abdominal
ultrasonography to endoscopic retrograde
pancreaticography and more recently CT scan
and Magnetic Resonance Cholangiography.
However, a preoperative diagnosis of carcinoid
tumour was made injust one case [5] and in only
11 cases was a diagnosis ofprimary CBD tumour
suspected. In three cases the diagnosis was made
13~~~~~~~~~~~~~~Z
at autopsyl3
The commonest site of malignant stricture was
thecommonbileduct(55%o) followedbythehilar
confluence of the bile ducts and the common
hepatic duct (33o). Notably, pain in the right
upper quadrant was a predominant symptom of
tumours in the cystic duct.
Fig 1. (200x magnification) Shows large malignantcells
withneuroendocrine granules positiveforNeurone
Specific Enolase by immunohistochemistry.
(Image inverted for clarity)
Metastatic spread was present in 14 cases (33%)
in which lymph node involvement was most
common site. Immunomarkers were not
performed in any case preoperatively and even
after diagnosis not all cases were tested. Positive
immunomarkers neurokinin, cromogranin,
gastrin, serotonin or argyroffin were detected in
10 cases and normal levels found in three,
including the present case.
Followupvariedfrom6to72monthsbutwas not
recorded in all cases. Survival in seven patients
was more than 24 months and four patients,
including two patients with lymph node
metastases, survived for more than 4 yrs.
In conclusion, carcinoid tumours of the extra
hepatic biliary tree are rare and occur in a young
age group with a preponderance in females.
Preoperative diagnosis is difficult but may be
improved with assessment of neuroendocrine
markers in suspectedcases. Diseasefree survival
is prolonged following surgical excision despite
the presence of metastases and these patients
should be treated aggressively.
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